The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

After hours: January 17 at 7:34:42 PM EST ...

Teva's long haul to a turnaround of its business ... and saddled with debt from its takeover of generics business Actavis. Since then, newer new drugs Austedo (deutetrabenazine) for Huntington's ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

1 Day TEVA 1.11% DJIA 0.78% S&P 500 1.00% Health Care/Life Sciences 66.70% ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.